Rare Diseases: Pharma Industry Calls For Collaboration, Political Commitment For Research

Big Pharma wants to develop treatments for rare diseases, with government support. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week launched a new report describing policy priorities to increase research and development into rare diseases.
Go to Source
Author: Catherine Saez

WordPress Video Lightbox
Cerca